INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,482,000 | -44.7% | 40,070 | -50.2% | 0.00% | -50.0% |
| Q4 2018 | $8,104,000 | -60.9% | 80,407 | -51.0% | 0.01% | -14.3% |
| Q3 2018 | $20,724,000 | +175.2% | 164,006 | +82.8% | 0.01% | +40.0% |
| Q2 2018 | $7,530,000 | +104.5% | 89,741 | +49.9% | 0.01% | +150.0% |
| Q1 2018 | $3,682,000 | +1.3% | 59,858 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $3,634,000 | -3.7% | 62,211 | -4.3% | 0.00% | -33.3% |
| Q3 2017 | $3,773,000 | -52.2% | 65,010 | -0.3% | 0.00% | -50.0% |
| Q2 2017 | $7,894,000 | +9.8% | 65,199 | +2.6% | 0.01% | +20.0% |
| Q1 2017 | $7,190,000 | +0.7% | 63,575 | -3.3% | 0.01% | 0.0% |
| Q4 2016 | $7,142,000 | +0.2% | 65,735 | +51.8% | 0.01% | +25.0% |
| Q3 2016 | $7,128,000 | +24.2% | 43,309 | +7.7% | 0.00% | 0.0% |
| Q2 2016 | $5,737,000 | +10.8% | 40,209 | -0.2% | 0.00% | 0.0% |
| Q1 2016 | $5,177,000 | -36.2% | 40,297 | -25.9% | 0.00% | -33.3% |
| Q4 2015 | $8,118,000 | -45.4% | 54,353 | -39.4% | 0.01% | -50.0% |
| Q3 2015 | $14,876,000 | -35.7% | 89,688 | -6.4% | 0.01% | -25.0% |
| Q2 2015 | $23,130,000 | +34.6% | 95,825 | +57.2% | 0.02% | +33.3% |
| Q1 2015 | $17,188,000 | +184.0% | 60,947 | +57.1% | 0.01% | +200.0% |
| Q4 2014 | $6,053,000 | -39.6% | 38,803 | -8.4% | 0.00% | -42.9% |
| Q3 2014 | $10,027,000 | +25.7% | 42,365 | +25.7% | 0.01% | +16.7% |
| Q2 2014 | $7,974,000 | -42.1% | 33,697 | -19.3% | 0.01% | -40.0% |
| Q1 2014 | $13,770,000 | -21.3% | 41,753 | -83.7% | 0.01% | -23.1% |
| Q4 2013 | $17,486,000 | +37.2% | 256,088 | +38.7% | 0.01% | +30.0% |
| Q3 2013 | $12,748,000 | +1034.2% | 184,670 | +636.6% | 0.01% | +900.0% |
| Q2 2013 | $1,124,000 | – | 25,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |